Peptide record

TPDB91245

cyclic dipeptide - 1b ACE inhibitors Antibacterial Anticancer Antifungal Antihypertensive Antioxidant iDPPIV modified_plain modified
2 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91245
cyclic dipeptide - 1b
ACE inhibitors Antibacterial Anticancer Antifungal Antihypertensive Antioxidant iDPPIV
Anti-infective peptides Cardiometabolic peptides Cancer-related peptides Functional / health-promoting peptides
Peptipedia CancerPPD 2.0 AHTPDB AHTpin AnOxPePred - 1.0 AODB Multi-AOP iDPPIV
modified_plain
Yes
A 2-aa modified multi-activity (ACE inhibitors, Antibacterial, Anticancer, and other sources) peptide sequence curated from Peptipedia, CancerPPD 2.0, AHTPDB, and other sources, with an available 3D structural model.
C-terminal: Cyclized Chemical: L-7dimethylallyl at Trp N-terminal: Cyclized
Sequence
WG
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
2 reviewed residue count
Cyclized Activity
L-7dimethylallyl at Trp Activity
L Activity
Cyclic Activity
Cyclized Activity
Anticancer Activity
Synthetic Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
IC50 = 95.3 µM
Anticancer
95.3 µM

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
72-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 87.7 µM
Anticancer
87.7 µM

Target

Liver Cancer
HepG-2
Liver

Assay & Model

MTT assay
72-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
Evidence 3 Activity

Activity

IC50
IC50 = 72.4 µM
Anticancer
72.4 µM

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
72-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
Evidence 4 Activity

Activity

IC50
IC50 = 33.7 µM
Anticancer
33.7 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
72-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020